Abstract
The experimental study of the cardioprotective effect of uridine, the metabolic precursor of the endogenous activator of mitochondrial ATP-dependent K+-channels (mitoKATP-channels), was performed using the model of myocardial ischemia/reperfusion injury (I/RP) in rats. Ischemia for 30 min followed by reperfusion for 120 min resulted in a significant decrease in the ATP and phosphocreatine (PCr) content, intensification of lipid peroxidation (LPO), and inhibition of the antioxidant system (AOS) in cardiomyocytes. Intravenous administration of uridine (30 mg/kg) had a protective effect on the myocardial metabolism in the zone of I/RP. It prevented the I/RP-induced decrease of ATP and PCr, limited LPO processes, evaluated by the content of lipid hydroperoxides (LHP) and conjugated dienes (CD), and improved the AOS state by, preventing a decrease of superoxide dismutase (SOD) activity and increasing the content of reduced glutathione (GSH). The intravenous injection of mitoKATP-channel blocker 5-hydroxydecanoate (5-HD, 5 mg/kg, 5 min before uridine) eliminated the ability of uridine to maintain the ATP level and to exhibit its positive effect on the intensity of the LPO and activity of AOS. The data obtained suggest that the activation of mitoKATP-channels plays an important role in the mechanism of the cardioprotective effect of uridine in the myocardial I/RP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.